The 20 Best Diffuse Large B-Cell Lymphoma (DLBCL) Doctors Near Me in Ypsilanti, MI

Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.

Dr. Carty completed her undergraduate work at Harvard University, graduating magna cum laude, with a degree in Biochemical Sciences. She attended the Albert Einstein College of Medicine in New York where she earned her MD degree. Dr. Carty stayed in New York for her internal medicine residency at Columbia University Medical Center, and moved to the Hospital of the University of Pennsylvania for her Hematology-Oncology fellowship. She remained on staff at the Hospital of the University of Pennsylvania before moving here to Ann Arbor. Dr. Carty is the recipient of a K08 Award for her work in T cell biology and ASH Scholar Award for her research on T cell lymphomas. Dr. Carty is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Carty is board certified in Hematology.

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.

Monalisa Ghosh, MD, Assistant Professor. Dr. Ghosh graduated with honors from the University of Alabama at Birmingham with a BS in Biomedical Engineering, minor in Mathematics and Chemistry. She earned her MD from the University of Alabama School of Medicine where she also completed her residency training. Her fellowship training was completed at the NIH/NCI Medical Oncology Fellowship Program. Dr. Ghosh’s research interest is in bone marrow trans-plantation and cellular therapies to treat lymphoma. Dr. Ghosh will be seeing patients on the BMT service. Dr. Ghosh is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Graft Versus Host Disease (GvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Colonoscopy.

Jerome Winegarden is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Winegarden is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Colorectal Cancer, Familial Colorectal Cancer, and Chronic Lymphocytic Leukemia (CLL).

Tareq Baghdadi is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Baghdadi is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, Tissue Biopsy, and Bone Marrow Aspiration.

Christopher Reynolds is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Reynolds is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), Neuroendocrine Tumor, and Bone Marrow Aspiration.

Niklas Mackler is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Mackler is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Lung Cancer.

Mark Kaminski is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Kaminski is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Gastric Lymphoma, and Bone Marrow Aspiration.

Thomas Regenbogen is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Regenbogen is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Carolyn Carrera is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Carrera is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Angiosarcoma.

Justin Shaya is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Shaya is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Thrombocytopenia, Adult Immune Thrombocytopenia, and Immune Thrombocytopenic Purpura (ITP).

Seth Stamberger is a primary care provider, practicing in Internal Medicine in Ypsilanti, Michigan. Dr. Stamberger is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Lung Cancer, Acute Tubular Necrosis, Sepsis, Endoscopy, and Ureteroscopy.

Elie Dib is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Dib is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Anemia, Myeloproliferative Neoplasms (MPN), Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

Erik Carson is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Carson is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Breast Cancer, and Paget Disease of the Breast.

The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Darren King is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 18 years. Dr. King is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. King is board certified in Hematology and Medical Oncology.

Attaphol Pawarode is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Pawarode is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Burke is board certified in Hematology and Medical Oncology.